{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:18:19Z","timestamp":1792653499881,"version":"4.5.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Potentially inappropriate prescribing (PIP) is common, costly, and harmful. Deprescribing potentially inappropriate medications (PIMs) is a priority for improving the health outcomes of older adults. PIP is especially common in long-term care homes, with up to 88% of residents affected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy of electronic decision support for deprescribing in long-term care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This stepped-wedge cluster randomized trial took place from August 1, 2021, to October 31, 2022, during the COVID-19 pandemic. The study assessed older adults residing in 1 of 5 long-term care homes in New Brunswick, Canada, at the start of the study who were prescribed 1 or more PIMs. The 5 long-term care homes were divided into 3 clusters. All clusters spent at least 3 months in a control phase; every 3 months a cluster was randomized to enter the intervention phase. Data analysis was performed from October 15, 2023, to March 24, 2025.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Electronically generated, individualized reports that contained prioritized opportunities for deprescribing in older adults were paired with preexisting quarterly medication reviews. Deprescribing reports were accessed through a secure viewer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcome was the proportion of residents with 1 or more PIMs deprescribed in the control phase vs intervention measured every 3 months after a medication review. For the primary outcome, an adjusted odds ratio (AOR) was calculated using a generalized linear model with a logit link, controlling for the effect of the intervention and adjusted for the number of PIMs, age, sex, language, and period as fixed effects and participants nested within sites as random effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 725 residents participated in the study (median [IQR] age, 84 [76-90] years; 478 [65.9%] female). The median (IQR) number of medications was 10 (7-13), and the median (IQR) number of PIMs was 3 (2-4). In the control phase, the proportion of residents with 1 or more PIMs deprescribed was 92 of 725 (12.7%) compared with 226 of 621 (36.4%) during the intervention (AOR, 1.58; 95% CI, 1.07-2.34), in favor of the intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study found that electronic decision support paired with the usual workflow could render the deprescribing process scalable and effective. These results suggest that medication reviews should incorporate deprescribing as part of usual care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT04762303\">NCT04762303<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.12931","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:30:32Z","timestamp":1748619032000},"page":"e2512931","source":"Crossref","is-referenced-by-count":10,"title":["Electronic Decision Support for Deprescribing in Older Adults Living in Long-Term Care"],"prefix":"10.1001","volume":"8","author":[{"given":"Emily G.","family":"McDonald","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine L.","family":"Estey","sequence":"additional","affiliation":[{"name":"The Centre for Innovation and Research in Aging, Fredericton, New Brunswick, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Davenport","sequence":"additional","affiliation":[{"name":"The Centre for Innovation and Research in Aging, Fredericton, New Brunswick, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Bortolussi-Courval","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gaudet","sequence":"additional","affiliation":[{"name":"Vitalit\u00e9 Health Network, Moncton, New Brunswick, Canada"},{"name":"Maritime SPOR SUPPORT Unit, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Philippe","family":"Wilson Registe","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Sherbrooke, Montreal, Qu\u00e9bec, Canada"},{"name":"Centre de Formation M\u00e9dicale du Nouveau Brunswick, Moncton, New Brunswick, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Goodine","sequence":"additional","affiliation":[{"name":"Horizon Health Network, Pharmacy Services, Doctor Everett Chalmers Regional Hospital, Fredericton, New Brunswick, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"1","key":"zoi250426r1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12877-024-04858-w","article-title":"Potentially inappropriate prescribing (PIP) in older people and its association with socioeconomic deprivation-a systematic review and narrative synthesis.","volume":"24","author":"Hire","year":"2024","journal-title":"BMC Geriatr"},{"issue":"11","key":"zoi250426r2","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3390\/jcm9113728","article-title":"The burden of potentially inappropriate medications in chronic polypharmacy.","volume":"9","author":"Guillot","year":"2020","journal-title":"J Clin Med"},{"issue":"7","key":"zoi250426r3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults.","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"zoi250426r4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice.","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"zoi250426r5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing.","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi250426r6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults.","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"8","key":"zoi250426r7","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/jcm11082229","article-title":"Adverse drug reactions and potentially inappropriate medication in older patients: analysis of the Portuguese pharmacovigilance database.","volume":"11","author":"Gomes","year":"2022","journal-title":"J Clin Med"},{"key":"zoi250426r8","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16382","article-title":"Adverse drug events in older adults: review of adjudication methods in deprescribing studies.","author":"Ross","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"zoi250426r9","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1111\/jgs.19164","article-title":"The cost of potentially inappropriate medications for older adults in Canada: a comparative cross-sectional study.","volume":"72","author":"Huon","year":"2024","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"zoi250426r10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/healthcare11030422","article-title":"Prevalence of potentially inappropriate prescriptions according to the new STOPP\/START criteria in nursing homes: a systematic review.","volume":"11","author":"D\u00edaz Planelles","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"4","key":"zoi250426r12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3.","volume":"14","author":"O\u2019Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"10","key":"zoi250426r13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1017\/S1041610220004032","article-title":"Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.","volume":"33","author":"Jester","year":"2021","journal-title":"Int Psychogeriatr"},{"issue":"10","key":"zoi250426r14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-022-00964-9","article-title":"ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.","volume":"39","author":"McCarthy","year":"2022","journal-title":"Drugs Aging"},{"issue":"12","key":"zoi250426r16","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/jgs.16777","article-title":"Statin discontinuation and life-limiting illness in non-skilled stay nursing homes at admission.","volume":"68","author":"Mack","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"zoi250426r17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jamda.2019.01.144","article-title":"Nursing home length of stay in 3 Canadian health regions: temporal trends, jurisdictional differences, and associated factors.","volume":"20","author":"Hoben","year":"2019","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"zoi250426r18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ijpp\/riad025","article-title":"A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.","volume":"31","author":"Omuya","year":"2023","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"zoi250426r19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-018-0536-4","article-title":"Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials.","volume":"35","author":"Thillainadesan","year":"2018","journal-title":"Drugs Aging"},{"issue":"3","key":"zoi250426r20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","article-title":"The MedSafer study-electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial.","volume":"182","author":"McDonald","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi250426r21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/jgs.19166","article-title":"Deprescribing is associated with reduced readmission to hospital: an updated meta-analysis of randomized controlled trials.","volume":"73","author":"Lee","year":"2025","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi250426r22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5770\/cgj.25.545","article-title":"MedSafer to support deprescribing for residents of long-term care: a mixed-methods study.","volume":"25","author":"Perri","year":"2022","journal-title":"Can Geriatr J"},{"issue":"1","key":"zoi250426r23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12877-021-02465-7","article-title":"Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.","volume":"21","author":"Cateau","year":"2021","journal-title":"BMC Geriatr"},{"issue":"4","key":"zoi250426r24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11096-020-01073-6","article-title":"Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.","volume":"42","author":"Balsom","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"zoi250426r25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jamda.2020.03.012","article-title":"Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trial.","volume":"22","author":"Kua","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"zoi250426r26","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab250","article-title":"Barriers and enablers to deprescribing in long-term care facilities: a \u2018best-fit\u2019 framework synthesis of the qualitative evidence.","volume":"51","author":"Heinrich","year":"2022","journal-title":"Age Ageing"},{"issue":"5","key":"zoi250426r27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jamda.2021.01.080","article-title":"Computerized decision support systems for nursing homes: a scoping review.","volume":"22","author":"Abdellatif","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"zoi250426r28","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231165712","article-title":"Electronic decision support for deprescribing in patients on hemodialysis: clinical research protocol for a prospective, controlled, quality improvement study.","author":"Bortolussi-Courval","year":"2023","journal-title":"Can J Kidney Health Dis"},{"issue":"12","key":"zoi250426r30","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/bcp.14101","article-title":"Pharmacist services in nursing homes: a systematic review and meta-analysis.","volume":"85","author":"Lee","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"zoi250426r36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi250426r38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1186\/s13063-021-05729-0","article-title":"Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.","volume":"22","author":"Nadeau","year":"2021","journal-title":"Trials"},{"issue":"3","key":"zoi250426r39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","article-title":"Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis.","volume":"20","author":"Kua","year":"2019","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"zoi250426r41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s11096-022-01419-2","article-title":"Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.","volume":"44","author":"Rowe","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"zoi250426r42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12877-016-0181-x","article-title":"Barricades and brickwalls\u2013a qualitative study exploring perceptions of medication use and deprescribing in long-term care.","volume":"16","author":"Palagyi","year":"2016","journal-title":"BMC Geriatr"},{"issue":"7","key":"zoi250426r43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1532-5415.2011.03418.x","article-title":"Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.","volume":"59","author":"Lapane","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi250426r44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/ageing\/afaa072","article-title":"Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.","volume":"49","author":"O\u2019Mahony","year":"2020","journal-title":"Age Ageing"},{"key":"zoi250426r11","unstructured":"Canadian Institute for Health Information. Dementia in long-term care. Published online 2024. Accessed October 20, 2024. https:\/\/www.cihi.ca\/en\/dementia-in-canada\/dementia-care-across-the-health-system\/dementia-in-long-term-care"},{"key":"zoi250426r15","unstructured":"Deprescribing.org. Deprescribing guidelines and algorithms. Accessed September 9, 2022. https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/"},{"key":"zoi250426r29","unstructured":"Canadian Institute for Health Information. Long-term care homes in Canada: how many and who owns them? Accessed March 22, 2025. https:\/\/www.cihi.ca\/en\/long-term-care-homes-in-canada-how-many-and-who-owns-them"},{"key":"zoi250426r31","unstructured":"Canadian Institute for Health Information. CIHI coding reference guide for the interRAI Home Care. Accessed April 20, 2025. https:\/\/secure.cihi.ca\/free_products\/cihi-coding-reference-guide-interrai-hc-manual-2025-en.pdf"},{"key":"zoi250426r32","unstructured":"Office of the Privacy Commission of Canada. The Personal Information Protection and Electronic Documents Act (PIPEDA). December 8, 2021. Accessed October 20, 2024. https:\/\/www.priv.gc.ca\/en\/privacy-topics\/privacy-laws-in-canada\/the-personal-information-protection-and-electronic-documents-act-pipeda\/"},{"key":"zoi250426r33","unstructured":"Choosing Wisely Canada. Gastroenterology. Accessed September 9, 2022. https:\/\/choosingwiselycanada.org\/recommendation\/gastroenterology\/"},{"key":"zoi250426r34","unstructured":"Choosing Wisely Canada. Psychiatry. Accessed September 9, 2022. https:\/\/choosingwiselycanada.org\/recommendation\/psychiatry\/"},{"key":"zoi250426r35","unstructured":"Choosing Wisely Canada. Less sedatives for your older relatives. Accessed March 2, 2024. https:\/\/choosingwiselycanada.org\/toolkit\/less-sedatives-for-your-older-relatives\/"},{"key":"zoi250426r37","unstructured":"Deprescribing Network. Do I still need this medication? is deprescribing for you? Accessed October 20, 2024. https:\/\/www.deprescribingnetwork.ca\/useful-resources"},{"key":"zoi250426r40","unstructured":"Appropriate Use Coalition. Rising rates: antipsychotic use in Canada\u2019s LTC homes. 2024. Accessed December 6, 2024. https:\/\/ltcmeds.ca\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834657\/mcdonald_2025_oi_250426_1747842047.55527.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:30:35Z","timestamp":1748619035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834657"}},"subtitle":["A Stepped-Wedge Cluster Randomized Trial"],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.12931","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}